129 related articles for article (PubMed ID: 7678045)
1. Myelodysplastic syndrome: diagnostic implications of cytochemical and immunocytochemical studies.
Seo IS; Li CY; Yam LT
Mayo Clin Proc; 1993 Jan; 68(1):47-53. PubMed ID: 7678045
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of immunocytochemical staining versus Giemsa stain for detecting dysmegakaryopoiesis in myelodysplastic syndromes (MDS).
Kawaguchi M; Nehashi Y; Aizawa S; Toyama K
Eur J Haematol; 1990 Feb; 44(2):89-94. PubMed ID: 2318299
[TBL] [Abstract][Full Text] [Related]
3. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes.
Thiele J; Titius BR; Kopsidis C; Fischer R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):275-82. PubMed ID: 1279889
[TBL] [Abstract][Full Text] [Related]
4. [Study on the implications of erythroblasts periodic acid-Schiff stain in myelodysplastic syndromes].
Liu L; Cui W; Zhang HL; Xu ZF; Zhang FK; Zheng YZ; Zhang Y; Qin TJ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):259-64. PubMed ID: 21569710
[TBL] [Abstract][Full Text] [Related]
5. [An immunohistochemical study on megakaryocytes in patients with myelodysplastic syndromes].
Liu SQ; Liu XF; Song SJ
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):288-90. PubMed ID: 7874762
[TBL] [Abstract][Full Text] [Related]
6. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
Thiele J; Quitmann H; Wagner S; Fischer R
J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
[TBL] [Abstract][Full Text] [Related]
7. [Significance of Morphological Examination, Cytochemical Staining Combined with Bone Marrow Biopsy in Differential Diagnosis of Myelodysplastic Syndrome with Low Blasts and Hemolytic Anemia].
Gu LL; Kang HY; Pan YL; Liu GX; Ge SJ; Li MY; Wang CB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):138-43. PubMed ID: 26913410
[TBL] [Abstract][Full Text] [Related]
8. CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia.
Huang J; Wang Z; Huang L; Zheng M
Leuk Res; 2018 Mar; 66():15-19. PubMed ID: 29353154
[TBL] [Abstract][Full Text] [Related]
9. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of utility of immunohistochemistry markers as a tool for objective diagnosis of low-grade myelodysplastic syndrome in routine reporting: Prospective observational study.
Juneja R; Pati H; Dange P; Gupta G; Mahapatra M; Tyagi S; Saxena R
Indian J Pathol Microbiol; 2022; 65(4):879-885. PubMed ID: 36308198
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
Das R; Hayer J; Dey P; Garewal G
Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
[TBL] [Abstract][Full Text] [Related]
12. Megakaryocytic alterations in thrombocytopenia: a bone marrow aspiration study.
Muhury M; Mathai AM; Rai S; Naik R; Pai MR; Sinha R
Indian J Pathol Microbiol; 2009; 52(4):490-4. PubMed ID: 19805953
[TBL] [Abstract][Full Text] [Related]
13. Cytochemistry and immunocytochemistry in bone marrow examination: contemporary techniques for the diagnosis of acute leukemia and myelodysplastic syndromes. A combined approach.
Kass L; Elias JM
Hematol Oncol Clin North Am; 1988 Dec; 2(4):537-55. PubMed ID: 3065317
[TBL] [Abstract][Full Text] [Related]
14. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
[TBL] [Abstract][Full Text] [Related]
16. Reevaluation of the periodic acid-Schiff stain in acute leukemia with immunophenotypic analyses.
Snower DP; Smith BR; Munz UJ; McPhedran P
Arch Pathol Lab Med; 1991 Apr; 115(4):346-50. PubMed ID: 1707262
[TBL] [Abstract][Full Text] [Related]
17. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
[TBL] [Abstract][Full Text] [Related]
18. Dysplasia features of myelodysplastic syndrome in ethnically Chinese people.
Xiong B; Tang ZH; Zou P; Yue QF; Chen WX; Liu XY
Acta Haematol; 2014; 131(2):126-32. PubMed ID: 24158033
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocytic ploidy in myelodysplastic syndromes.
Kobayashi Y; Ozawa M; Maruo N; Kondo M
Leuk Lymphoma; 1993 Jan; 9(1-2):55-61. PubMed ID: 8477202
[TBL] [Abstract][Full Text] [Related]
20. Acute leukemia of adults. Ultrastructural, cytochemical and histologic observations in 100 cases.
Glick AD; Paniker K; Flexner JM; Graber SE; Collins RD
Am J Clin Pathol; 1980 Apr; 73(4):459-70. PubMed ID: 6154412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
